Comparison of Commercial Low Molecular Weight Heparin and Homemade Anti-Xa Calibrators to a Commercial Specific Anti-Xa Calibrator for Plasma Rivaroxaban Quantification by Anti-Xa Oral Anticoagulant Plasma Concentration Chromogenic Assay

被引:1
|
作者
Divsalar, Bita [1 ,2 ]
Kalantari, Tahereh [1 ,2 ]
Mohebbi, Soheila [1 ,2 ]
Bahmanimehr, Ardeshir [3 ]
Shahsavani, Amin [3 ,4 ]
Borhani-Haghighi, Afshin [5 ]
机构
[1] Shiraz Univ Med Sci, Sch Paramed Sci, Dept Lab Sci, Div Hematol & Blood Banking, Shiraz, Iran
[2] Shiraz Univ Med Sci, Sch Paramed Sci, Diagnost Lab Sci & Technol Res Ctr, Shiraz, Iran
[3] Shiraz Univ Med Sci, Dastgheib Hosp, PND Res Ctr, Thalassemia & Hemophilia Genet, Shiraz, Iran
[4] Shiraz Univ Med Sci, Hematol Res Ctr, Shiraz, Iran
[5] Shiraz Univ Med Sci, Clin Neurol Res Ctr, Shiraz, Iran
关键词
Anti-Xa; homemade calibrator made by spiked normal pooled plasma; NPP; laboratory; low molecular weight heparin; rivaroxaban; CLINICAL-PRACTICE; APIXABAN;
D O I
10.1093/labmed/lmac137
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective The main concern about measuring the concentration of rivaroxaban by anti-Xa assay in some laboratories is the lack of a commercial specific calibrator in emergencies. Therefore, this study aimed at providing a homemade anti-Xa calibrator and commercial low molecular weight heparin (LMWH) anti-Xa calibrator. Methods The anti-Xa plasma concentration of rivaroxaban was measured in 70 patients using a commercial specific anti-Xa calibrator, a commercial LMWH anti-Xa calibrator, and a homemade anti-Xa calibrator. Results We demonstrated a significant correlation and agreement (P < .001) between LMWH-calibrated anti-Xa and the commercial specific calibrator. A significant correlation (P < .001) was found between homemade calibrated anti-Xa made by normal pooled plasma and that calibrated with a commercial specific drug. The nonspecific homemade and LMWH calibrators had excellent agreement (P < .001) and can be used interchangeably. Conclusion Our data showed that for estimating rivaroxaban concentrations, the LMWH calibrator could be used as an alternative calibrator in the anti-Xa assay.
引用
收藏
页码:400 / 405
页数:6
相关论文
共 50 条
  • [21] Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins
    Hesham S. Al-Sallami
    Michael A. Barras
    Bruce Green
    Stephen B. Duffull
    [J]. Clinical Pharmacokinetics, 2010, 49 : 567 - 571
  • [22] Using an old test for new tricks: Measuring direct oral anti-Xa drug levels by conventional heparin-calibrated anti-Xa assay
    Maier, Cheryl L.
    Asbury, William H.
    Duncan, Alexander
    Robbins, Adele
    Ingle, Ann
    Webb, Adam
    Stowell, Sean R.
    Roback, John D.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (05) : E132 - E134
  • [23] Comparison of apixaban and rivaroxaban trough anti-Xa activity.
    Bookstaver, David
    Sparks, Kimberly
    Pybus, Brandon
    Davis, Dustin
    [J]. PHARMACOTHERAPY, 2016, 36 (12): : E239 - E239
  • [24] Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins
    Al-Sallami, Hesham S.
    Barras, Michael A.
    Green, Bruce
    Duffull, Stephen B.
    [J]. CLINICAL PHARMACOKINETICS, 2010, 49 (09) : 567 - 571
  • [25] Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator
    Burger, Annika
    Studt, Jan-Dirk
    Mendez, Adriana
    Alberio, Lorenzo
    Fontana, Pierre
    Wuillemin, Walter A.
    Schmidt, Adrian
    Graf, Lukas
    Gerber, Bernhard
    Bovet, Cedric
    Sauter, Thomas C.
    Binder, Nikolaus B.
    Nagler, Michael
    [J]. DIAGNOSTICS, 2023, 13 (12)
  • [26] Comparison of Anti-Xa Activity in Patients Receiving Apixaban or Rivaroxaban
    Bookstaver, David A.
    Sparks, Kimberly
    Pybus, Brandon S.
    Davis, Dustin K.
    Marcsisin, Sean R.
    Sousa, Jason C.
    [J]. ANNALS OF PHARMACOTHERAPY, 2018, 52 (03) : 251 - 256
  • [27] AUTOMATED ASSAYS FOR ACTIVE HEPARIN CONCENTRATION AND ANTI-XA FUNCTIONALITY
    PERRY, JF
    SIEFRING, GE
    JANES, CJ
    [J]. THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 139 - 139
  • [28] Comparison of 8 commercial Anti-Xa assays and the heparin assay by protamine titration in patients receiving unfractionated heparin
    Theaker, J
    Kitchen, S
    Philips, JK
    Preston, FE
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P1133 - P1133
  • [29] Evaluation of the new DG-Chrom Anti-Xa kit from Grifols for detection and quantification of new oral anti-Xa anticoagulants
    Ambros, R.
    Montanini, V
    Civit, G.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 565 - 565
  • [30] Using a single calibration curve with the anti-Xa chromogenic assay for monitoring heparin anticoagulation
    McGlasson, DL
    [J]. LABORATORY MEDICINE, 2005, 36 (05) : 297 - 299